Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Rectal Neoplasms × Control Groups × Clear all

Phase

Phase NA 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1 Rectal Neoplasms 1 Postoperative Analgesia 1 Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Fluorouracil 5 Oxaliplatin 4 Surgical Procedures, Operative 3 Radiotherapy 3 Neoadjuvant Therapy 3 Leucovorin 3 Drug Therapy 3 Chemoradiotherapy 3 Capecitabine 3 Irinotecan 2 Immune Checkpoint Inhibitors 2 Folfox protocol 2 Bevacizumab 2 sulindac sulfone 1 sintilimab 1 XELOX 1 Water 1 Surveys and Questionnaires 1 Preoperative Exercise 1 Photochemotherapy 1 N-dihydrogalactochitosan 1 Microwaves 1 Mental Status and Dementia Tests 1 Magnetic Resonance Spectroscopy 1 Leucine-tRNA Ligase 1 Injections 1 Indocyanine Green 1 In Situ Hybridization, Fluorescence 1 Immunohistochemistry 1 HMPL-013 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07505472 2026-04-01

STARS-RC10

The First Hospital of Jilin University

Phase 2/3 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡